Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

Validation of tissue microarray technology in malignant peripheral nerve sheath tumours

2009; BMJ; Volume: 62; Issue: 7 Linguagem: Inglês

10.1136/jcp.2008.063081

1472-4146

Karin Soares Cunha, Anabela Cunha Caruso, A Soares Gonçalves, Vagner Gonçalves Bernardo, Andréia Rodrigues Cordovil Pires, Eliene Carvalho da Fonseca, Paulo Antônio Silvestre de Faria, Licínio Esmeraldo da Silva, Mauro Geller, Rodrigo S. Moura‐Neto, V Silami Lopes,

Multiple Myeloma Research and Treatments

Background: It has been suggested that the donor tissue cores used in tissue microarrays (TMAs) may not be representative of the whole tissue section. Aim: To validate the use of TMA technology in the study of malignant peripheral nerve sheath tumours (MPNSTs). Methods: A TMA was constructed containing five independent core biopsy samples of 14 formalin-fixed, paraffin-embedded MPNSTs. The immunohistochemical (IHC) results of the five cores from the same tissue block on TMA were compared with readings from whole sections using two antibodies: anti-Ki-67 and anti-S-100. Digital image analysis was performed to calculate the percentage of positive stain areas. The agreement between IHC results obtained with TMA cores and whole sections was assessed using the κ statistic. Results: There was good to very good agreement between IHC results for whole and TMA sections from MPNSTs. In relation to S-100, very good agreement (92% agreement; κ = 0.77) was observed using a minimum of four TMA cores. Staining results for Ki-67 from at least four readable TMA cores were the same as those for the whole section in 86% of cases, with good agreement, using weighted κ statistics (κ = 0.63). Conclusions: This study indicates that the TMA technique can be used in the IHC study of MPNSTs, even with the use of heterogeneous markers such as S-100 protein.